The X-ray Crystallographic Structure of the Angiogenesis Inhibitor Angiostatin

Angiogenesis inhibitors have gained much public attention recently as anti-cancer agents and several are currently in clinical trials, including angiostatin (Phase I, Thomas Jefferson University Hospital, Philadelphia, PA). We report here the bowl-shaped structure of angiostatin kringles 1–3, the fi...

Full description

Saved in:
Bibliographic Details
Published inJournal of molecular biology Vol. 318; no. 4; pp. 1009 - 1017
Main Authors Abad, Marta C., Arni, R.K., Grella, Davida K., Castellino, Francis J., Tulinsky, Alexander, Geiger, James H.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 10.05.2002
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Angiogenesis inhibitors have gained much public attention recently as anti-cancer agents and several are currently in clinical trials, including angiostatin (Phase I, Thomas Jefferson University Hospital, Philadelphia, PA). We report here the bowl-shaped structure of angiostatin kringles 1–3, the first multi-kringle structure to be determined. All three kringle lysine-binding sites contain a bound bicine molecule of crystallization while the former of kringle 2 and kringle 3 are cofacial. Moreover, the separation of the kringle 2 and kringle 3 lysiner binding sites is sufficient to accommodate the α-helix of the 30 residue peptide VEK-30 found in the kringle 2/VEK-30 complex. Together the three kringles produce a central cavity suggestive of a unique domain where they may function in concert.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-2836
1089-8638
DOI:10.1016/S0022-2836(02)00211-5